CIBC Private Wealth Group
CODX

CIBC Private Wealth Group’s Co-Diagnostics CODX Stock Holding History

CIBC Private Wealth Group’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-33
Closed -$280 – 3132
2025
Q2 		$280 Hold
33
– – ﹤0.01% 2885
2025
Q1 		$299 Hold
33
– – ﹤0.01% 2932
2024
Q4 		$775 Sell
33
-22
-40% -$695 ﹤0.01% 2819
2024
Q3 		$2.08K Hold
55
– – ﹤0.01% 2794
2024
Q2 		$2.06K Hold
55
– – ﹤0.01% 2748
2024
Q1 		$1.84K Buy
+55
New +$1.99K ﹤0.01% 2771

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CIBC Private Wealth Group's CODX Position: Q3 2025 in Review

CIBC Private Wealth Group sold out of Co-Diagnostics (CODX) in Q3 2025, closing a stake of 33 shares — an estimated $280 sold.

CIBC Private Wealth Group first reported a position in CODX in Q1 2024 and held it in 6 quarters. The position peaked at $2.08K in Q3 2024. 33 funds tracked by Wall St. Rank hold CODX as of Q3 2025.

  • CIBC Private Wealth Group reported no remaining Co-Diagnostics position as of Q3 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 33 Co-Diagnostics shares in Q3 2025, an estimated $280.
  • CIBC Private Wealth Group first reported a position in Co-Diagnostics in Q1 2024 and held it in 6 quarters.
  • CIBC Private Wealth Group's Co-Diagnostics position peaked at $2.08K in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2025.

Based on CIBC Private Wealth Group's 13F filing for Q3 2025, filed 24 Nov 2025.